Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
0.46 USD -2.87% Intraday chart for RedHill Biopharma Ltd. -0.80% -68.49%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REDHILL BIOPHARMA LTD.
Biopharmaceuticals
-2.87%-0.80%-68.49%-78.30%-99.84% 14.66M
Bullish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. Charts RedHill Biopharma Ltd.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW